formaldehyde has been researched along with 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amano, T; Deyama, S; Kaneda, K; Minami, M; Mori, S; Sugano, Y; Yoshioka, M | 1 |
1 other study(ies) available for formaldehyde and 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide
Article | Year |
---|---|
Activation of the NMDA receptor-neuronal nitric oxide synthase pathway within the ventral bed nucleus of the stria terminalis mediates the negative affective component of pain.
Topics: Animals; Conditioning, Operant; Cyclic N-Oxides; Disease Models, Animal; Excitatory Postsynaptic Potentials; Formaldehyde; Free Radical Scavengers; Hydroxylamines; Imidazoles; Male; Membrane Potentials; Neurons; Nitric Oxide Synthase Type I; Nitro Compounds; Pain; Pain Management; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Septal Nuclei; Signal Transduction | 2017 |